Inflammatory environment and immune responses to oxidized LDL are linked to systolic and diastolic blood pressure levels in hypertensive subjects

International Journal of Cardiology

Volumn 157, Issue 1, 2012, Pages 131-133

  Da Fonseca, Henrique Andrade Rodrigues ^a   Fonseca, Francisco Antonio Helfenstein ^a,c   Monteiro, Andrea Moreira ^b,c   Farias Jr , Nelson Carvalho ^c   Bianco, Henrique Tria ^a   Brandão, Sergio Augusto Bueno ^a   Póvoa, Rui Manoel Dos Santos ^a   Gidlund, Magnus ^b   Izar, Maria Cristina De Oliveira ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c National Institute of Complex Fluids   (Brazil)

Author keywords

Autoantibodies; Blood pressure; Hypertension; Immune system; OxLDL

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN C; APOLIPOPROTEIN D; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIBODY TITER; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84860262336     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.041     Document Type: Article

References (16)

1. T.D. Liao, X.P. Yang, and Y.H. Liu Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension Hypertension 52 2008 256 263
2. G.C. Meléndez, J.L. McLarty, S.P. Levick, Y. Du, J.S. Janicki, and G.L. Brower Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats Hypertension 56 2010 225 231
3. C. Stumpf, C. Auer, and A. Yilmaz Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension Hypertens Res 34 2011 484 488
4. V. Dauphinot, F. Roche, and M.P. Kossovsky C-reactive protein implications in new-onset hypertension in a healthy population initially aged 65 years: the Proof study J Hypertens 27 2009 736 743
5. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
6. S.A. Brandão, M.C. Izar, and S.M. Fischer Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control Am J Hypertens 23 2010 208 214
7. R. Wu, U. de Faire, C. Lemne, J.L. Witztum, and J. Frostegård Autoantibodies to OxLDL are decreased in individuals with borderline hypertension Hypertension 33 1999 53 59
8. A.E. Fraley, and S. Tsimikas Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease Curr Opin Lipidol 17 2006 502 509
9. A.O. Santos, F.A. Fonseca, and S.M. Fischer High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation Clin Chim Acta 406 2009 113 118
10. S.R. Soares, R. Carvalho-Oliveira, and E. Ramos-Sanchez Air pollution and antibodies against modified lipoproteins are associated with atherosclerosis and vascular remodeling in hyperlipemic mice Atherosclerosis 207 2009 368 373
11. A.M. Medeiros, C.A. von Mühlen, M.A. Gidlund, R. Bodanese, M.G. Gottlieb, and L.C. Bodanese Antibodies against oxLDL and acute coronary syndrome Arq Bras Cardiol 95 2010 47 54
12. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
13. H. Puhl, G. Waeg, and H. Esterbauer Methods to determine oxidation of low-density lipoprotein Methods Enzymol 233 1994 425 441
14. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
15. E.C. Fernvik, D.F. Ketelhuth, M. Russo, and M. Gidlund The autoantibody repertoire against cooper- or macrophage-modified LDL differs in normolipidemics and hypercholesterolemic patients J Clin Immunol 24 2004 170 176
16. A.J.S. Coats, and L.G. Shewan Statement on authorship and publishing ethics in the international journal of cardiology Int J Cardiol 153 2011 239 240